Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis-Reference-Cited by-同舟云学术

Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis

Published:1990-04 Issue:4 Volume:98 Page:1029-1035
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

García-Monzón Carmelo,Moreno-Otero Ricardo,Pajares JoséM.,García-Sánchez Asunción,López-Botet Miguel,de Landázuri Manuel O.,Sánchez-Madrid Francisco

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Chronic hepatitis: a problem for the pathologist;Scheuer;Histopathology,1977

2. Cellular and humoral immune reactions in chronic active liver disease. I. lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis;Eggink;Clin Exp Immunol,1982

3. Involvement of the cytotoxic/suppressor T cell subset in liver tissue injury of patients with acute and chronic liver diseases;Pape;Gastroenterology,1983

4. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis;Colucci;Gastroenterology,1983

5. Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content;Cotner;J Exp Med,1983

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pivotal role of CD69 in autoimmunity;Journal of Autoimmunity;2020-07

Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs

;Drug Design, Development and Therapy;2019-10

3. Dysregulation of CD69 by overexpression of microRNA‑367‑3p associated with post‑myocardial infarction cardiac fibrosis;Molecular Medicine Reports;2018-06-29

4. Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis;Journal of the American Society of Nephrology;2016-05-05

5. Is CD69 an effective brake to control inflammatory diseases?;Trends in Molecular Medicine;2013-10